Get startedLog in
    Picture of Harmony Biosciences Holdings logo

    HRMY — Harmony Biosciences Holdings Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Harmony Biosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUS10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-152-36.934.6181129
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items6535.444.529.744.6
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital8.29-11.60.631-4.1135
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities-75.4-2.9898.6144219
    Capital Expenditures-75.1-0.002-100-40.2-0.312
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-52-2—-102-46.1
    Acquisition of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-127-2-100-142-46.4
    Financing Cash Flow Items-6.32-36.1-31.50-9.36
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities1442097.426.84-106
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-58.82045.689.4767.4